465093381	465093381	CD	B-NP	O
|	|	NN	I-NP	O
DESCMH	DESCMH	NN	I-NP	O
|	|	NN	I-NP	O
64572761	64572761	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
105004	105004	CD	B-NP	O
|	|	CC	I-NP	O
2/6/2001	2/6/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ARRYTHMIA	ARRYTHMIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/9/2001	11/9/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/16/2001	3/16/2001	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
52-year-old	52-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
lupus	lupus	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
mastectomy	mastectomy	NN	I-NP	O
and	and	CC	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
pauses	pause	NNS	B-NP	O
of	of	IN	B-PP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
6.6	6.6	CD	I-NP	O
seconds	second	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Holter	Holter	NNP	I-NP	O
monitor	monitor	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
pacer	pacer	NN	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
since	since	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
noted	note	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
exercise	exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
noticed	notice	VBN	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
palpitation	palpitation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
put	put	VBD	B-VP	O
a	a	DT	B-NP	O
Holter	Holter	NNP	I-NP	O
monitor	monitor	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
10/1/01	10/1/01	CD	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
rates	rate	NNS	B-NP	O
between	between	IN	B-PP	O
67	67	CD	B-NP	O
and	and	CC	I-NP	O
214	214	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
117	117	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Esmond	Esmond	NNP	I-NP	O
,	,	,	O	O
initially	initially	RB	B-ADVP	O
put	put	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
rate	rate	NN	I-NP	O
remained	remain	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
changed	change	VBD	B-VP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
to	to	TO	B-PP	O
Cardizem	Cardizem	NNP	B-NP	O
.	.	.	O	O

About	About	RB	B-NP	O
one	one	CD	I-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
added	add	VBD	B-VP	O
propafenone	propafenone	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
On	On	IN	B-PP	O
10/5	10/5	CD	B-NP	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Cowser	Cowser	NNP	I-NP	O
,	,	,	O	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
continued	continue	VBN	B-NP	O
palpitations	palpitation	NNS	I-NP	O
and	and	CC	O	O
ankle	ankle	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
her	her	PRP	B-NP	O
Cardizem	Cardizem	NNP	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	DT	B-NP	O
was	be	VBD	B-VP	O
what	what	WP	B-NP	O
was	be	VBD	B-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
placed	place	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	RB	B-ADVP	O
instead	instead	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
leepy	leepy	JJ	I-NP	O
Holter	Holter	NNP	I-NP	O
monitor	monitor	NN	I-NP	O
placed	place	VBN	B-VP	O
from	from	IN	B-PP	O
8/29/23	8/29/23	CD	B-NP	O
.	.	.	O	O

Wednesday	Wednesday	NNP	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
having	have	VBG	B-VP	O
episodes	episode	NNS	B-NP	O
where	where	WRB	B-ADVP	O
``	``	``	O	O
I	I	PRP	B-NP	O
felt	feel	VBD	B-VP	O
my	my	PRP$	B-NP	O
heart	heart	NN	I-NP	O
pause	pause	NN	I-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
surge	surge	NN	B-NP	O
when	when	WRB	B-ADVP	O
it	it	PRP	B-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
beat	beat	VB	I-VP	O
again	again	RB	B-ADVP	O
''	''	''	O	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
lightheadedness	lightheadedness	NN	B-NP	O
x	x	SYM	B-VP	O
several	several	JJ	B-NP	O
seconds	second	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
associated	associate	VBN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	I-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	I-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
or	or	CC	I-NP	O
syncope	syncope	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
called	call	VBD	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Cedotal	Cedotal	NNP	I-NP	O
on	on	IN	B-PP	O
6/16	6/16	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
told	tell	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
her	her	PRP$	B-NP	O
atenolol	atenolol	NN	I-NP	O
and	and	CC	O	O
continue	continue	VB	B-VP	O
her	her	PRP$	B-NP	O
propafenone	propafenone	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
flutter	flutter	NN	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
irregular	irregular	JJ	B-NP	O
heart	heart	NN	I-NP	O
beat	beat	NN	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
since	since	IN	B-PP	O
stopping	stop	VBG	B-VP	O
the	the	DT	B-NP	O
atenolol	atenolol	NN	I-NP	O
on	on	IN	B-PP	O
Wednesday	Wednesday	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
noted	note	VBN	I-VP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
days	day	NNS	B-NP	O
,	,	,	O	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
climbing	climb	VBG	B-VP	O
one	one	CD	B-NP	O
flight	flight	NN	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
using	use	VBG	B-VP	O
two	two	CD	B-NP	O
pillows	pillow	NNS	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
PND	PND	NN	B-NP	O
,	,	,	O	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
10/25/01	10/25/01	CD	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Mcferrin	Mcferrin	NNP	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
transmitted	transmit	VBN	I-NP	O
Holter	Holter	NNP	I-NP	O
recording	record	VBG	B-VP	O
from	from	IN	B-PP	O
Viewden	Viewden	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
rates	rate	NNS	I-NP	O
but	but	CC	O	O
also	also	RB	B-ADVP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
6.6	6.6	CD	B-NP	O
second	second	JJ	I-NP	O
pauses	pause	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
called	call	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	O	O
her	her	PRP	B-NP	O
sent	send	VBN	B-VP	O
via	via	IN	B-PP	O
ambulance	ambulance	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cole	Cole	NNP	I-NP	O
General	General	NNP	I-NP	O
Health	Health	NNP	I-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
for	for	IN	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
pacemaker	pacemaker	NN	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vitals	vital	NNS	I-NP	O
were	be	VBD	B-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
112	112	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
150/81	150/81	CD	I-NP	O
,	,	,	O	O
breathing	breathing	NN	B-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
sweats	sweat	NNS	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
syncope	syncope	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	I-NP	O
dysuria	dysuria	NN	I-NP	O
or	or	CC	I-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
she	she	PRP	B-NP	O
revealed	reveal	VBD	B-VP	O
40	40	CD	B-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
GENERAL	GENERAL	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
52-year-old	52-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
resting	rest	VBG	B-VP	O
comfortably	comfortably	RB	B-ADVP	O
at	at	IN	B-PP	O
45	45	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
moist	moist	NN	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
veins	vein	NNS	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
around	around	IN	B-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Wheezing	Wheeze	VBG	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
both	both	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1S2	S1S2	NN	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
S4	S4	NN	I-NP	B-protein
and	and	CC	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
3/6	3/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
loudest	loud	JJS	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
1/6	1/6	CD	I-NP	O
diastolic	diastolic	JJ	I-NP	O
decrescendo	decrescendo	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NNP	B-NP	O
,	,	,	O	O
well	well	RB	B-VP	O
perfused	perfuse	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	B-protein
146	146	CD	I-NP	I-protein
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.6	3.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
117	117	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
19	19	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NNP	B-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
120	120	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
76	76	CD	I-NP	I-protein
,	,	,	O	O
troponin	troponin	NN	B-NP	B-protein
0	0	CD	I-NP	I-protein
,	,	,	O	O
CBC	CBC	NNP	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
8.73	8.73	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
29.1	29.1	CD	I-NP	I-protein
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
around	around	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
30-38	30-38	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
289	289	CD	B-NP	O
.	.	.	O	O

ESR	ESR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
75	75	CD	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
what	what	WP	B-NP	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
3.1	3.1	CD	B-NP	O
Chest	Chest	NNP	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
redistribution	redistribution	NN	I-NP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
94	94	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
left	leave	VBN	I-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
echo	echo	NN	I-NP	O
done	do	VBN	B-VP	O
at	at	IN	B-PP	O
MH	MH	NN	B-NP	O
on	on	IN	B-PP	O
10/13/01	10/13/01	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
63	63	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
concentric	concentric	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
preserved	preserve	VBN	B-VP	O
,	,	,	O	O
a	a	DT	B-NP	O
thickened	thicken	VBN	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
plus	plus	CC	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
thickened	thicken	VBD	B-VP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
AI	AI	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
AS	AS	NN	I-NP	O
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
moderately	moderately	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
plus	plus	CC	O	O
her	her	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
made	make	VBD	B-VP	O
notes	note	NNS	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
echo	echo	NN	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
done	do	VBN	B-VP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
prior	prior	RB	B-ADVP	O
at	at	IN	B-PP	O
BKTMC	BKTMC	NN	B-NP	B-cell_type
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Breast	Breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
mastectomy	mastectomy	NN	B-NP	O
with	with	IN	B-PP	O
lymph	lymph	NN	B-NP	O
node	node	NN	I-NP	O
dissection	dissection	NN	I-NP	O
in	in	IN	B-PP	O
5/1	5/1	CD	B-NP	O
Pathology	Pathology	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
invasive	invasive	JJ	B-NP	O
ductal	ductal	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
,	,	,	O	O
grade	grade	NN	B-NP	B-protein
3/3	3/3	CD	I-NP	I-protein
,	,	,	O	O
node	node	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
four	four	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
of	of	IN	B-PP	O
Adriamycin	Adriamycin	NN	B-NP	O
and	and	CC	I-NP	O
cytoxan	cytoxan	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
lupus	lupus	NN	B-NP	B-protein
x	x	SYM	O	I-protein
21	21	CD	B-NP	I-protein
years	year	NNS	I-NP	I-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
diagnosed	diagnose	VBN	B-VP	O
three	three	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	B-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Prevacid	Prevacid	NN	B-NP	O
30	30	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
chloroquine	chloroquine	NN	B-NP	O
100	100	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Plaquenil	Plaquenil	NN	B-NP	O
200	200	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
;	;	:	O	O
Flovent	Flovent	NNP	B-NP	O
220	220	CD	B-NP	O
2-3	2-3	CD	I-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
;	;	:	O	O
Flonase	Flonase	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
propafenone	propafenone	NN	B-NP	O
150	150	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Tetracycline	Tetracycline	NN	B-NP	O
which	which	WDT	B-NP	O
give	give	VBP	B-VP	O
her	her	PRP$	B-NP	O
nausea	nausea	NN	I-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	O	O
sometimes	sometimes	RB	B-ADVP	O
she	she	PRP	B-NP	O
got	get	VBD	B-VP	O
that	that	IN	B-SBAR	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
nurse	nurse	NN	I-NP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
medical	medical	JJ	I-NP	O
leave	leave	NN	I-NP	O
of	of	IN	B-PP	O
absence	absence	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

Tobacco	Tobacco	NNP	B-NP	O
history	history	NN	I-NP	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
smoke	smoke	VB	I-VP	O
1	1	CD	B-NP	O
pack	pack	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
since	since	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
23	23	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ethanol	ethanol	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Brother	Brother	NN	B-NP	O
with	with	IN	B-PP	O
sarcoid	sarcoid	NN	B-NP	O
plus	plus	CC	O	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

Father	Father	RB	B-ADVP	O
with	with	IN	B-PP	O
prostate	prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
From	From	IN	B-PP	O
an	an	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
she	she	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
continue	continue	VB	I-VP	O
her	her	PRP$	B-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
From	From	IN	B-PP	O
a	a	DT	B-NP	O
pump	pump	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
we	we	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
perhaps	perhaps	RB	B-NP	O
her	her	PRP$	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
2-3	2-3	NN	I-NP	O
month	month	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
exercise	exercise	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
got	get	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
borderline	borderline	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
moderately	moderately	RB	I-VP	O
thickened	thicken	VBN	I-VP	O
and	and	CC	O	O
rheumatic	rheumatic	JJ	B-ADJP	O
in	in	IN	B-PP	O
appearance	appearance	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	JJ	I-NP	O
area	area	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
1.3	1.3	CD	B-NP	O
cm	cm	NN	I-NP	O
squared	square	VBD	B-VP	O
although	although	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
under	under	IN	B-PP	O
estimate	estimate	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
was	be	VBD	B-VP	O
calcified	calcify	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
mild	mild	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
regurgitant	regurgitant	JJ	I-NP	O
velocity	velocity	NN	I-NP	O
of	of	IN	B-PP	O
3.5	3.5	CD	B-NP	O
consistent	consistent	JJ	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
48	48	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
her	her	PRP$	B-NP	O
severe	severe	JJ	I-NP	O
and	and	CC	I-NP	O
symptomatic	symptomatic	JJ	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
we	we	PRP	B-NP	O
then	then	RB	B-ADVP	O
decided	decide	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
likely	likely	RB	I-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
we	we	PRP	B-NP	O
proceeded	proceed	VBD	B-VP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
left	left	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
system	system	NN	I-NP	O
with	with	IN	B-PP	O
clean	clean	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
and	and	CC	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
and	and	CC	O	O
elevated	elevate	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
31	31	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
several	several	JJ	B-NP	O
kg	kg	NN	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
weight	weight	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
ace	ace	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
for	for	IN	B-PP	O
afterload	afterload	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

Consultation	Consultation	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mazingo	Mazingo	NNP	I-NP	O
of	of	IN	B-PP	O
cardiothoracic	cardiothoracic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
patient	patient	NN	B-NP	O
would	would	MD	B-VP	O
indeed	indeed	RB	I-VP	O
benefit	benefit	VB	I-VP	O
greatly	greatly	RB	B-ADVP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
MVR	MVR	NN	I-NP	B-protein
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
plan	plan	NN	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
and	and	CC	O	O
then	then	RB	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
readmitted	readmitte	VBN	I-VP	O
electively	electively	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
Dr.	Dr.	NNP	B-NP	O
Brocks	Brocks	NNP	I-NP	O
returned	return	VBD	B-VP	O
from	from	IN	B-PP	O
vacation	vacation	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MVR	MVR	NN	I-NP	B-protein
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
propafenone	propafenone	NN	I-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
excellent	excellent	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
pauses	pause	NNS	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
given	give	VBN	B-PP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
pauses	pause	NNS	I-NP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	O
blockade	blockade	NN	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
need	need	VB	I-VP	O
pacemaker	pacemaker	NN	B-NP	O
placement	placement	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
From	From	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
we	we	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
likely	likely	RB	B-ADJP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
as	as	IN	B-PP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
her	her	PRP$	B-NP	O
wheezing	wheezing	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
was	be	VBD	B-VP	O
nearly	nearly	RB	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
improved	improve	VBN	B-VP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Rheumatology	Rheumatology	NNP	I-NP	O
:	:	:	O	O
From	From	IN	B-PP	O
a	a	DT	B-NP	O
rheumatologic	rheumatologic	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
her	her	PRP$	B-NP	O
lupus	lupus	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
typical	typical	JJ	I-NP	O
lupus	lupus	NN	I-NP	O
flare	flare	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
arthralgias	arthralgia	NNS	B-NP	O
or	or	CC	O	O
rash	rash	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
and	and	CC	O	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Plaquenil	Plaquenil	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
chloroquine	chloroquine	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
renal	renal	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
lupus	lupus	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
cytic	cytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
at	at	IN	B-PP	O
29	29	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
29-38	29-38	CD	B-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
anemia	anemia	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Prophylaxis	Prophylaxis	NNP	I-NP	O
:	:	:	O	O
From	From	IN	B-PP	O
a	a	DT	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
so	so	RB	B-ADVP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
considered	consider	VBN	I-VP	O
for	for	IN	B-PP	O
heparin	heparin	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Prilosec	Prilosec	NNP	B-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Plaquenil	Plaquenil	NN	B-NP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
magnesium	magnesium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
2	2	CD	B-NP	O
grams	gram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
;	;	:	O	O
propafenone	propafenone	NN	B-NP	O
225	225	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
K-Dur	K-Dur	NN	B-NP	O
60	60	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
Flovent	Flovent	NNP	B-NP	O
220	220	CD	B-NP	O
mg	mg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	NN	B-NP	O
;	;	:	O	O
Flonase	Flonase	NN	B-NP	O
2	2	CD	B-NP	O
sprays	spray	NNS	I-NP	O
nasally	nasally	RB	B-ADJP	O
q.d.	q.d.	RB	I-ADJP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
allergies	allergy	NNS	I-NP	O
and	and	CC	O	O
postnasal	postnasal	JJ	B-NP	O
drip	drip	NN	I-NP	O
;	;	:	O	O
Prevacid	Prevacid	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
chloroquine	chloroquine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
FOLLOWUP	FOLLOWUP	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Flecther	Flecther	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
's	's	POS	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Druvenga	Druvenga	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
'	'	POS	B-NP	O
time	time	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
returned	return	VBD	B-VP	O
from	from	IN	B-PP	O
vacation	vacation	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
would	would	MD	B-VP	O
then	then	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
elective	elective	JJ	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
MVR	MVR	NN	B-NP	B-protein
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
CARLO	CARLO	NNP	B-NP	O
FINNICUM	FINNICUM	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BY60	BY60	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TIMMY	TIMMY	NNP	B-NP	O
GREGG	GREGG	NNP	I-NP	O
KOSSAKOWSKI	KOSSAKOWSKI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AY1	AY1	NNP	I-NP	O
GI185/303022	GI185/303022	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
04935	04935	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

NNSZTM4XXQ	NNSZTM4XXQ	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/1/01	1/1/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/26/01	6/26/01	CD	B-NP	O

